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no such regional difference in type I collagen content in low-grade control
specimens (p=0.181).
Real-time PCR: COL2A1 expression was not signiﬁcantly different in regions
of damaged and preserved cartilage in AMG (p=0.156), low-grade control
(p=0.625) or high-grade control specimens (p=0.813). COL1A1 expression
in AMG specimens was signiﬁcantly greater in the preserved cartilage than
damaged cartilage (p=0.031). However, the regional difference in type I
collagen expression was not seen in low-grade (p=0.625) or high-grade
controls (p=0.219).
Conclusions: Type I collagen is abundant in ﬁbro-cartilage but only found
in very low levels in mature hyaline cartilage and is not usually found
in articular cartilage. Macroscopically normal cartilage in AMG exhibits
increased COL1A1 gene expression and a subsequent increase in type I
collagen matrix content. Type I collagen is also increased in the equivalent
region of knees with early histological features of OA
These ﬁndings suggest that these cartilage matrix and chondrocyte pheno-
type changes may be an early feature of OA change in AMG.
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Purpose: Previous studies have suggested that TWEAK may have an
important role in stimulating bone and cartilage destruction in various
arthritidies. The aim of this study was to investigate TWEAK and TWEAK
receptor (Fn14) expression in the cartilage and synovial tissues from os-
teoarthritic and normal (healthy) individuals. Protein expression of TWEAK
and TWEAK receptors (Fn14) was determined in cartilage from samples of
various grades of osteoarthritis (OA) and synovial tissue from patients with
OA and normal controls. TWEAK and Fn14 gene expression was studied in
various grades of OA cartilage. In addition, levels of soluble TWEAK present
in OA synovial ﬂuid were measured.
Methods: Synovial tissues from total of 10 OA and 10 normal subjects were
studied for TWEAK and Fn14 using immunohistochemistry. Osteoarthritic
cartilage was obtained from 21 patients undergoing primary hip replace-
ment and stained for TWEAK and Fn14 expression. Staining was assessed
using a standard semi-quantitative assessment carried out by two inde-
pendent observers. In addition, mRNA levels of TWEAK and Fn14 were
determined by real time RT PCR in the various grades of cartilage tissue.
TWEAK levels were measured in 15 OA synovial ﬂuid samples using a
commercial ELISA kit.
Results: Signiﬁcantly higher TWEAK (Figure 1A and B) and Fn14 was
detected in OA synovial tissue compared to the normal synovial tissue
(p<0.05) and expression was predominantly in the synovial lining.
In OA cartilage, the majority (18/21) all grades of samples expressed
TWEAK protein at low levels, whereas all samples (OA and normal) ex-
pressed high levels of Fn14 (Figure 1C and D). TWEAK and Fn14 mRNA was
more abundant in OA patients (Figure 2) with grade 2 cartilage damage
compared to those without any cartilage damage (p<0.05). TWEAK was
present in all OA synovial ﬂuids tested at a mean concentration of 713±134
pg/ml.
Figure 1. Synovial tissue expression of TWEAK (red stain) in OA and normal (B) tissues.
Cartilage tissue expression of Fn14 (red stain) in grade 2 (C) and grade 0 (D) tissues.
Conclusions: Previous studies have shown that TWEAK can induce met-
alloproteinase production in vitro by human chondrocytes and in murine
Figure 2. TWEAK and Fn14 mRNA in various grades of OA cartilage.
intervertebral disc tissues. As yet no studies have directly investigated the
presence of TWEAK and its receptor (FN14) in human OA tissues. The high
expression of Fn14 by chondrocytes in OA cartilage indicates that these
cells are able to respond to TWEAK. In OA tissues TWEAK was expressed
by chondrocytes in cartilage and highly expressed in the adjacent synovial
tissues. This is consistent with TWEAK protein in the OA synovial ﬂuid.
Overall the study indicates that TWEAK released from the synovial tissue
and chondrocytes in OA has a role in cartilage degradation.
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Purpose: Recent evidence has indicated a relationship between osteoarthri-
tis and altered glycosylation of cartilage and chondrocytes. Although the
glycobiology of cells is known to affect adhesion, receptor activity or
apoptosis, little information exists on the N- or O-glycome of human chon-
drocytes and on their signiﬁcance for the functionality of cartilage tissue. In
part, this fact may result from the methodological challenges encountered
with low glycosyltransferase transcription levels and linkage-type speciﬁc
glycoprotein glycan analysis. This study aimed to elucidate the glycome
of cultured human chondrocytes using a combination of RT-qPCR and
structural glycan analysis (LC-ESI-MS) and to deﬁne alterations of cellular
glycans upon treatment of chondrocytes with pro-inﬂammatory cytokines.
Methods: Primary chondrocytes were isolated from human OA cartilage
(n=8). Primary cells, SW1353 and C-28/I2 chondrocytes were cultured
in DMEM with 10% FCS or 1% ITS. 10 ng/ml IL-1β or 40 ng/ml TNF-α
were added as a pro-inﬂammatory stimulus. SYBR green based RT-qPCR
assays for 19 glycosyltransferases and 5 galectins were established using
GAPDH as reference. N- and O-glycan isolation was performed by PNGase
(N-glycans) or sodium hydroxide (O-Glycan) digestion prior to structural
identiﬁcation by LC-ESI-MS using Porous Graphitized Carbon as stationary
phase.
Results: About 100 different N- and O-glycans were detected and quan-
tiﬁed in human chondrocytes in the presence or absence of FCS. Major
N-glycans were found as sialylated diantennary structures, oligomannosidic
or hybrid-type glycans. The isomers of diantennary and oligomannosidic
N-glycans were fully assigned. Some structures were sulfated, contained
GalNAc or Lewis fucose residues, whereas tri and tetraantennary glycans
were present only to a minor extent. O-glycosylation mainly constituted of
core-1 and core-2 structures bearing one or two α2,3 linked sialic acids.
Primary chondrocytes predominantly expressed α2,6-speciﬁc sialyltrans-
ferases (SiaT) and α2,6-linked sialic acid residues in glycoprotein N-glycans.
In contrast, the preponderance of α2,3-linked sialyl residues and reduced
levels of α2,6-speciﬁc SiaT were associated with the altered chondrocyte
phenotype of C-28/I2 and SW1353 cells. Importantly, we found that both
IL-1β and TNF-α increased overall sialylation of N- and O-glycans and
induced a shift towards α2,3-linked sialic acid residues in primary chon-
drocyte glycoproteins. These results were supported by RT-qPCR showing
increased expression of α2,3 SiaT in treated cells. Moreover, we found
that both cytokines induced a considerable shift from oligomannosidic
glycans towards complex-type N-glycans, whereas core α1,6-fucosylation
was found to be reduced particularly by TNF-α.
